Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription

This publication has 37 references indexed in Scilit:

• Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group
  Published by American Medical Association (AMA) ,1996
• Present Status and Future Prospects for HIV Therapies
  Science, 1993
• New insights into the mechanism of HIV-1 trans-activation
  Trends in Genetics, 1992
• Pseudo—Half-Knot Formation with RNA
  Science, 1992
• THE BIOCHEMISTRY OF AIDS
  Annual Review of Biochemistry, 1991
• A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
  Genes & Development, 1990
• Tat trans-activates the human immunodeficiency virus through a nascent RNA target
  Cell, 1989
• HIV-1 tat trans-activation requires the loop sequence within tar
  Nature, 1988
• Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein
  Cell, 1987
• The trans-activator gene of HTLV-III is essential for virus replication
  Nature, 1986